Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Diav-Citrin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Early Pregnancy|November 24, 2001
Adverse environment and prevention of early pregnancy disordersO Diav-Citrin, A Ornoy
Pediatric Clinics of North America|February 1, 1997
Oral iron chelation with deferiproneO Diav-Citrin, G Koren
Therapeutic Drug Monitoring|March 2, 1999
An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia majorO Diav-Citrin, G Atanackovic, G Koren
American Journal of Perinatology|August 24, 1999
Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort studyO Diav-Citrin, B Okotore, K Lucarelli, et al.
Canadian Family Physician Medecin De Famille Canadien|February 8, 2000
Zopiclone use during pregnancyO Diav-Citrin, B Okotore, K Lucarelli, et al.
Neurology|July 27, 2001
Is carbamazepine teratogenic? A prospective controlled study of 210 pregnanciesO Diav-Citrin, S Shechtman, J Arnon, et al.
American Journal of Hematology|February 3, 1999
Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literatureO Diav-Citrin, L Hunnisett, G D Sher, et al.
Canadian Family Physician Medecin De Famille Canadien|February 7, 2001
Universal HIV testing in pregnancyS Ratnapalan, O Diav-Citrin, S M King, et al.
Paediatric Drugs|August 11, 2000
Medication errors in paediatrics: a case report and systematic review of risk factorsO Diav-Citrin, S Ratnapalan, M Grouhi, et al.
Teratology|April 26, 2001
Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort studyO Diav-Citrin, S Shechtman, T Gotteiner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Early Pregnancy|November 24, 2001
Adverse environment and prevention of early pregnancy disordersO Diav-Citrin, A Ornoy
Pediatric Clinics of North America|February 1, 1997
Oral iron chelation with deferiproneO Diav-Citrin, G Koren
Therapeutic Drug Monitoring|March 2, 1999
An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia majorO Diav-Citrin, G Atanackovic, G Koren
American Journal of Perinatology|August 24, 1999
Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort studyO Diav-Citrin, B Okotore, K Lucarelli, et al.
Canadian Family Physician Medecin De Famille Canadien|February 8, 2000
Zopiclone use during pregnancyO Diav-Citrin, B Okotore, K Lucarelli, et al.
Neurology|July 27, 2001
Is carbamazepine teratogenic? A prospective controlled study of 210 pregnanciesO Diav-Citrin, S Shechtman, J Arnon, et al.
American Journal of Hematology|February 3, 1999
Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literatureO Diav-Citrin, L Hunnisett, G D Sher, et al.
Canadian Family Physician Medecin De Famille Canadien|February 7, 2001
Universal HIV testing in pregnancyS Ratnapalan, O Diav-Citrin, S M King, et al.
Paediatric Drugs|August 11, 2000
Medication errors in paediatrics: a case report and systematic review of risk factorsO Diav-Citrin, S Ratnapalan, M Grouhi, et al.
Teratology|April 26, 2001
Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort studyO Diav-Citrin, S Shechtman, T Gotteiner, et al.
Pageof 2